Sign in

CIK 0001175680 · Non-accelerated filer<br>Smaller reporting company

CytoDyn Inc.

Sign in to watch
Ticker
CYDY
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
May 31
Incorporated
DE
Entity type
operating
EIN
753056237
Phone
360-980-8524
Business address
1111 MAIN STREET, SUITE 660, VANCOUVER, WA, 98660
Former names
CYTODYN INC, REXRAY CORP
  1. 8-K Event Executive or director change
  2. 4 Grant or award CFO acquired 10,807 shares (grant or award)
  3. 4 Grant or award CMO acquired 15,234 shares (grant or award)
  4. 4 Grant or award Chief Technology Officer acquired 13,671 shares (grant or award)
  5. 4 Grant or award CMO acquired 17,922 shares (grant or award)
  6. 4 Grant or award CFO acquired 12,714 shares (grant or award)
  7. 4 Grant or award Chief Technology Officer acquired 16,084 shares (grant or award)
  8. 4 Derivatives Options or other derivatives
  9. 3 Insider Initial Statement of Ownership
  10. 8-K Event Regulation FD disclosure · Other events
  11. DEF 14A Proxy Proxy Statement
  12. 8-K Event Executive or director change
  13. 4 Grant or award Chief Technology Officer acquired 12,428 shares (grant or award)
  14. 4 Grant or award CFO acquired 9,824 shares (grant or award)
  15. 4 Grant or award CMO acquired 13,849 shares (grant or award)
  16. 10-Q/A Report 10-Q/A
  17. 10-Q Report Quarterly Report
  18. 4 Grant or award CMO acquired 18,793 shares (grant or award)
  19. 4 Grant or award Chief Technology Officer acquired 13,020 shares (grant or award)
  20. 4 Grant or award CFO acquired 10,292 shares (grant or award)

Page 11 of 71 · 1,401 filings